Skip to main content
Clinical Trials/EUCTR2016-002210-46-NL
EUCTR2016-002210-46-NL
Active, not recruiting
Phase 1

Study: Reduces intravenous lidocaine the need for alfentanyl during colonoscopy under Procedural Sedation and Analgesia?

niversity Medical Centre RadboudUMC0 sites76 target enrollmentJuly 28, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Medical Centre RadboudUMC
Enrollment
76
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 28, 2016
End Date
November 27, 2018
Last Updated
5 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversity Medical Centre RadboudUMC

Eligibility Criteria

Inclusion Criteria

  • Colonoscopy performed under PSA
  • Age 18\-65 years
  • Inflammatory bowel disease: Crohn’s disease or ulcerative colitis
  • Informed consent
  • ASA classification 1 or 2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 76
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • Emergency colonoscopy.
  • Known allergies for study medication
  • Known rhythm disorders i.e. second or third degree AV block
  • Obstructive sleep apnea syndrome
  • Uncontrolled hypertension

Outcomes

Primary Outcomes

Not specified

Similar Trials